← Back to headlines
TG Therapeutics Secures $750M Credit Facility, Boosts Buyback to $300M
TG Therapeutics has successfully secured a $750 million credit facility with Blue Owl and simultaneously announced an increase in its share buyback program to $300 million.
19 Mar, 11:38 — 19 Mar, 11:38
Sources
Showing 1 of 1 sources
Related Stories
European Stock Markets, Including Athens and Milan, Decline Amid Middle East Conflict
6m ago
Dax Falls Below 23,000 Points Amid Middle East Conflict
10m ago
Powell Warns Iran Conflict Narrows Fed's Rate Cut Path, Threatens New Inflation
11m ago
AFMA Reports MAD 317 Million Revenue in 2025, Driven by SAFE ASSUR Acquisition
12m ago